Project Details
Description
Project Summary/Abstract
The adaptive immune system protects the host from a second infection by generating infection-specific
lymphocytes called memory cells. Memory cells come from a much larger population of effector cells, which
are generated from rare naïve cells that proliferate after antigen binds to their antigen receptors. The objective
of this project is to understand CD4+ memory T cell formation in the context of a persistent infection with the
phagosomal pathogen Salmonella enterica serovar Typhimurium (Se) that is controlled by CD4+ T cells. Se
infection generates a large population of interferon-gamma-producing CD4+ T cells (Th1 cells) that is stably
maintained but declines slowly if infection is eliminated. Although the vast majority of cells in the Th1
population have a quiescent memory cell-phenotype during persistent infection, the numerical stability of the
population is associated with intermittent bursts of antigen-driven proliferation by a small number of cells. The
Th1 population consists of two IL-12-dependent subsets, one expressing CXCR3 and the other CX3CR1, both
of which play roles in Se protection. We hypothesize that the vast majority of CXCR3+ Th1 cells are maintained
by IL-7 like true memory cells but interact intermittently with rare infected macrophages and undergo T cell
receptor-driven proliferation to produce terminally differentiated CX3CR1+ cells and more CXCR3+ Th1 memory
cells. We posit that the CXCR3+ Th1 cells that undergo repeated cycles of intermittent stimulation become
capable of indefinite survival without the infection. Here, we will test these hypotheses using adoptive transfer
and cell ablation experiments and use the results to design vaccines that produce immunity without a
persistent infection. Completion of these aims would yield basic information about CD4+ memory T cells in
contexts where they are critical for immunity and give clues about how to make vaccines for some of the
world’s most deadly pathogens.
Status | Active |
---|---|
Effective start/end date | 4/1/96 → 8/31/24 |
Funding
- National Institute of Allergy and Infectious Diseases: $462,000.00
- National Institute of Allergy and Infectious Diseases: $489,823.00
- National Institute of Allergy and Infectious Diseases: $252,558.00
- National Institute of Allergy and Infectious Diseases: $248,852.00
- National Institute of Allergy and Infectious Diseases: $456,000.00
- National Institute of Allergy and Infectious Diseases: $252,586.00
- National Institute of Allergy and Infectious Diseases: $485,277.00
- National Institute of Allergy and Infectious Diseases: $252,502.00
- National Institute of Allergy and Infectious Diseases: $349,557.00
- National Institute of Allergy and Infectious Diseases: $461,500.00
- National Institute of Allergy and Infectious Diseases: $349,501.00
- National Institute of Allergy and Infectious Diseases: $462,000.00
- National Institute of Allergy and Infectious Diseases: $160,408.00
- National Institute of Allergy and Infectious Diseases: $356,382.00
- National Institute of Allergy and Infectious Diseases: $252,531.00
- National Institute of Allergy and Infectious Diseases: $377,500.00
- National Institute of Allergy and Infectious Diseases: $354,850.00
- National Institute of Allergy and Infectious Diseases: $494,284.00
- National Institute of Allergy and Infectious Diseases: $360,399.00
- National Institute of Allergy and Infectious Diseases: $345,948.00
- National Institute of Allergy and Infectious Diseases: $458,500.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.